Free. Unsubscribe any time.
X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals, Inc filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 5 transactions and 214,287 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2025-01-27, came on the same day as the one before it (2025-01-27) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 76,473 shares, 1,700 more than the 74,773 in the filing before it.
- Its 5 filings on file run from 2025-01-27 to 2025-01-27, and state one plan adoption date, 2024-06-28.
Trades in X4 Pharmaceuticals, Inc 5
- Arbet-Engels Christophe — 2025-01-24 · S · 11,624 shares
- Baldry Mark — 2025-01-24 · S · 29,159 shares
- DiBiase Mary — 2025-01-24 · S · 22,258 shares
- Mostafa Adam S. — 2025-01-24 · S · 74,773 shares
- Ragan Paula — 2025-01-24 · S · 76,473 shares
Adoption dates in X4 Pharmaceuticals, Inc 1
- 2024-06-28 — stated in 5 filings
Results prints in X4 Pharmaceuticals, Inc 0
Trades before a print in X4 Pharmaceuticals, Inc 0
Interval to X4 Pharmaceuticals, Inc’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 5no later print
Adoption dates X4 Pharmaceuticals, Inc states
- 2024-06-28 in 5 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 28, 2024”
Sources: SEC EDGAR full-text search and the SEC submissions API.